In an IMI APPROACH cohort, an inflammation biomarker subtype aligned with worse knee osteoarthritis pain outcomes across ...

The ATS/ERS 2025 statement on interstitial pneumonia classification updates the 2013 statement, with insights on secondary ...

Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing ...

Researchers at Kumamoto University have demonstrated that iron supplementation can significantly alleviate muscle pathology ...

The future of health innovation will not be defined by replacing existing medical models, but by strengthening biological ...

Researchers have examined cellular crosstalk between the gut and liver during sepsis, helping us better understand sepsis ...

Researchers at the University Health Network and University of Toronto led the discovery of a possible biomarker linked to multiple sclerosis (MS ...

The involvement of glial cells in Alzheimer's disease (AD) has been mostly viewed as a secondary adaptive response to ...

HistoIndex partners with Houston Research Institute to expand advanced MASH diagnostic services: Singapore Thursday, January 22, 2026, 10:00 Hrs [IST] HistoIndex, a pioneer in AI- ...

New nanomaterial passes the blood-brain barrier to reduce damaging inflammation after the most common form of stroke. When ...

Bringing regenerative medicine, longevity science, and advanced mental-health therapies to the Great Lakes Bay Region ...

Dietary taurine supplementation reduced neuroinflammation and pathology in Alzheimer’s disease models. Learn more about its ...